Oligomerix Announces Board Changes: Vic Micati Appointed Chairman and Jack Pasini Appointed Company Director and Chief Commercial Officer

Oligomerix Awarded NIH Grant to Develop Novel Biomarkers for Alzheimer’s Disease

Oligomerix funded by the Alzheimer’s Drug Discovery Foundation to evaluate compounds active against tau oligomers, a novel target for therapeutic development

Victor P. Micati Joins OLIGOMERIX’s Board of Directors

Oligomerix Awarded NIH Grant to Develop Novel Drug Discovery Technology for Alzheimer’s Disease